How Groundbreaking ADCs Are Helping More Patients With MBC at AshTip Solution.

AshTip NewsLetter |Antibody-drug conjugates (ADCs), a class of potent biopharmaceutical agents that target specific cancer cells, are associated with relevant antitumor activity across breast cancer subtypes. Medscape recently spoke with experts in metastatic breast cancer (MBC) — Avan J.

Medscape

How Groundbreaking ADCs Are Helping More Patients With MBC

How Groundbreaking ADCs Are Helping More Patients With MBC

Antibody-drug conjugates (ADCs), a class of potent biopharmaceutical agents that target specific cancer cells, are associated with relevant antitumor activity across breast cancer subtypes. Medscape recently spoke with experts in metastatic breast cancer (MBC) — Avan J. Armaghani, MD; Aditya Bardia, MD, MPH; and Paolo Tarantino, MD — about sequencing ADCs for patients with MBC. Read on for their insights.